Microphysiological Systems (Tissue Chips) and their Utility for Rare Disease Research

Area of Science:

• Biotechnology
• Regenerative Medicine
• Microfluidics

Background:

• Microphysiological systems (MPS), also known as organs-on-chips or tissue chips (TCs), have advanced significantly.
• Integration of stem cell research and microfluidic technologies has enabled the creation of diverse human organ models.
• These platforms offer potential for rare disease research and therapeutic development.

Purpose of the Study:

• To review the current state and challenges in tissue chip research.
• To explore the application of tissue chips in modeling rare diseases.
• To highlight the utility of tissue chips in drug discovery and development.

Main Methods:

• Development of microfluidic platforms.
• Application of stem cell technologies.
• Modeling of human organ systems.

Main Results:

• Tissue chips can model rare disease pathologies at cellular and molecular levels.
• These systems show potential for screening existing therapeutics and testing new drugs.
• Tissue chips may serve as alternatives to animal testing for drug development.

Conclusions:

• Tissue chip technology is a rapidly advancing field with significant implications for rare disease research.
• These bioengineered platforms offer novel tools for understanding disease mechanisms and accelerating drug discovery.
• Tissue chips hold promise for personalized medicine and reducing reliance on animal models.